Serious health hazard — there is a reasonable probability that use of or exposure to this product will cause serious adverse health consequences or death.
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension Recalled by Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy Due to Subpotent drug
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy directly.
Affected Products
Tacrolimus (Brand Capsules ) 0.5 mg/mL Suspension, Rx, This is a compounded medication., Valor Compounding Pharmacy, 2461 Shattuck Ave., Berkeley, CA 94704,
Quantity: 1,966 mLs in 12 oz; 2 oz; 16 oz and 6 oz bottles
Why Was This Recalled?
Subpotent drug
Where Was This Sold?
This product was distributed to 1 state: CA
About Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy
Valor Compounding Pharmacy, Inc DBA Valor Compounding Pharmacy has 3 total recalls tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report